SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy

被引：0
|
作者：
Bologna, Cinzia [1 ,2 ]
Buonincontri, Roberta [1 ,2 ]
Serra, Sara [2 ]
Vaisitti, Tiziana [1 ,2 ]
Audrito, Valentina [2 ]
Brusa, Davide [1 ,2 ]
Pagnani, Andrea [2 ]
Coscia, Marta [3 ]
D'Arena, Giovanni [4 ]
Bhavsar, Erica B. [5 ]
Furman, Richard R. [6 ]
Rossi, Davide [7 ]
Gaidano, Gianluca [7 ]
Terhorst, Cox [8 ]
Deaglio, Silvia [1 ,2 ]
机构：
[1] Univ Turin, Dept Med Sci, Turin, Italy
[2] Human Genet Fdn, Turin, Italy
[3] AO Citta Salute & Sci, Div Hematol, Turin, Italy
[4] IRCCS Ctr Riferimento Oncol Basilicata, Hematol & Stem Cell Transplantat Unit, Rionero In Vulture, Italy
[5] Weill Cornell Med Coll, Dept Hematol Oncol, New York, NY USA
[6] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[7] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Translat Med, Novara, Italy
[8] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Immunol, Sch Med, Boston, MA 02215 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] CD154 (CD40-ligand) gene therapy of chronic lymphocytic leukemia patients leads to anamnestic T cell responses.
    Rassenti, LZ
    Cielinska, SM
    Kipps, TJ
    BLOOD, 1999, 94 (10) : 601A - 601A
  • [22] Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells
    Li, Ping
    Harris, David
    Liu, Zhiming
    Liu, Jie
    Keating, Michael
    Estrov, Zeev
    PLOS ONE, 2010, 5 (07):
  • [23] Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells
    Acebes-Huerta, Andrea
    Huergo-Zapico, Leticia
    Gonzalez-Rodriguez, Ana Pilar
    Fernandez-Guizan, Azahara
    Payer, Angel R.
    Lopez-Soto, Alejandro
    Gonzalez, Segundo
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [24] The Elastin Microfibril Interfacer-1 (EMILIN-1) Is a Ligand for CD49d in Chronic Lymphocytic Leukemia Cells
    Tissino, Erika
    Benedetti, Dania
    Bomben, Riccardo
    Dal Bo, Michele
    Vaisitti, Tiziana
    Deaglio, Silvia
    Rossi, Davide
    Zaja, Francesco
    Pozzato, Gabriele
    Di Raimondo, Francesco
    Gaidano, Gianluca
    Del Poeta, Giovanni
    Zamo, Alberto
    Spessotto, Paola
    Doliana, Roberto
    Zucchetto, Antonella
    Colombatti, Alfonso
    Gattei, Valter
    BLOOD, 2012, 120 (21)
  • [25] Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia
    Benjamini, Ohad
    Shimoni, Avichai
    Besser, Michal
    Shem-Tov, Noga
    Danylesko, Ivetta
    Yerushalmi, Ronit
    Merkel, Drorit Grizim
    Tadmor, Tamar
    Lavie, David
    Fineman, Riva
    Jacobi, Elad
    Nagler, Arnon
    Avigdor, Abraham
    BLOOD, 2020, 136
  • [26] CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation
    Pittner, BT
    Shanafelt, TD
    Kay, NE
    Jelinek, DF
    LEUKEMIA, 2005, 19 (12) : 2264 - 2272
  • [27] CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation
    B T Pittner
    T D Shanafelt
    N E Kay
    D F Jelinek
    Leukemia, 2005, 19 : 2264 - 2272
  • [28] Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
    Beyer, M
    Kochanek, M
    Darabi, K
    Popov, A
    Jensen, M
    Endl, E
    Knolle, PA
    Thomas, RK
    von Bergwelt-Baildon, M
    Bebey, S
    Hallek, M
    Schultze, JL
    BLOOD, 2005, 106 (06) : 2018 - 2025
  • [29] Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells
    Yu, J.
    Chen, L.
    Chen, Y.
    Hasan, M. K.
    Ghia, E. M.
    Zhang, L.
    Wu, R.
    Rassenti, L. Z.
    Widhopf, G. F.
    Shen, Z.
    Briggs, S. P.
    Kipps, T. J.
    LEUKEMIA, 2017, 31 (12) : 2608 - 2614
  • [30] Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
    Manna, Alak
    Kellett, Timothy
    Aulakh, Sonikpreet
    Lewis-Tuffin, Laura J.
    Dutta, Navnita
    Knutson, Keith
    Chini, Eduardo
    Pinilla-Ibarz, Javier
    Lamanna, Nicole
    Manochakian, Rami
    Malavasi, Fabio
    Sher, Taimur
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    Paulus, Aneel
    BLOOD ADVANCES, 2020, 4 (10) : 2143 - 2157
12345